Received Feb 4, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MENB | MENINGOCOCCAL B (BEXSERO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | UNK | — |
has product complaint-did not administer to patient as vaccine appears viscous in syringe and unable to remove air bubble; has product complaint-did not administer to patient as vaccine appears viscous in syringe and unable to remove air bubble; has product complaint-did not administer to patient as vaccine appears viscous in syringe and unable to remove air bubble; This non-serious case was reported by a nurse via sales rep and described the occurrence of incomplete course of vaccination in a adult patient who did not receive Men B NVS (Bexsero) for prophylaxis. This case was associated with a product complaint. The patient did not receive Bexsero. The patient experienced incomplete course of vaccination (Verbatim: has product complaint-did not administer to patient as vaccine appears viscous in syringe and unable to remove air bubble), product appearance cloudy (Verbatim: has product complaint-did not administer to patient as vaccine appears viscous in syringe and unable to remove air bubble) and pharmaceutical product complaint (Verbatim: has product complaint-did not administer to patient as vaccine appears viscous in syringe and unable to remove air bubble). The outcome of the incomplete course of vaccination, product appearance cloudy and pharmaceutical product complaint were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: Upon internal review the case was updated on 05-JAN-2026 The case was considered as valid. The batch number was not provided and a request for this information has been made.